Browse our 1,000+ Publications​

Vania Hungria, Paweł Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, P Joy Ho, Roman Hájek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Aparecida Martinez, Anna Sureda Balarí, Irwindeep Sandhu, Claudio Cerchione, Peter Ganly, Meletios A Dimopoulos, Chengcheng Fu, Mamta Garg, Al-Ola Abdallah, Moshe E Gatt, Albert Oriol Rocafiguera, Michele Cavo, Robert Rifkin, Tomoaki Fujisaki, Michał Mielnik, Joseph Ficek, Alejandro Mantero, Nick Pirooz, Sybil Varghese, Joe Lee, Astrid McKeown, Rachel Rogers, Hena Baig, Lydia Eccersley, Sumita Roy-Ghanta, Pralay Mukhopadhyay, Jacqueline Nielsen, Joanna Opalinska, María-Victoria Mateos, on behalf of the DREAMM-7 study investigators Clinica São Germano, São Paulo, Brazil (V Hungria MD); Medical University of Łódź, Łódź, Poland (Prof P Robak MD); Samodzielny Publiczny Szpital Kliniczny, Lublin, Poland (Prof M Hus MD, M Mielnik MD); Gorodskaya Klinicheskaya Bol’nitsa Im Sp Botkina, Moscow, Russia (V Zherebtsova MD); Royal North Shore Hospital, Sydney, NSW, Australia (Prof C Ward MD); Royal Prince Alfred Hospital, Camperdown, NSW, Australia (Prof P J Ho MBBS); University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic (Prof R Hájek MD); Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea (Prof K Kim MD); Medical University of Silesia, Katowice, Poland (Prof S Grosicki MD); Pindara Private Hospital, Gold Coast, QLD, Australia (H Sia MBBS); Liverpool Hospital, Sydney, NSW, Australia (A Bryant PhD); Universidade da Região de Joinville and Centro de Hematologia e Oncologia, Joinville, Santa Catarina, Brazil (Prof M Pitombeira de Lacerda MD); Hospital das Clínicas and Instituto do Câncer do Estado de São Paulo, Universidade de São Paulo, São Paulo, Brazil (G A Martinez MD); Institut Català d’Oncologia- L’Hospitalet L.-Barcelona, Barcelona, Spain (A Sureda Balarí MD); Cross Cancer Institute, Edmonton, AB, Canada (I Sandhu MD); Hematology Unit, Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST IRCCS, Meldola, Forlì-Cesena, Italy (C Cerchione MD); Christchurch Hospital, Christchurch, New Zealand (P Ganly PhD); School of Medicine, National and Kapodistrian University of Athens, Athens, Greece (Prof M A Dimopoulos MD); Korea University, Seoul, South Korea (Prof M A Dimopoulos); The First Affiliated Hospital of Soochow University, Jiangsu, China (Prof C Fu MD); University Hospitals of Leicester NHS Trust, Leicester, UK (M Garg MD); University of Kansas Cancer Center, Fairway, KS, USA (A-O Abdallah MD); Department of Haematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel (M E Gatt MD); Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain (A Oriol Rocafiguera MD); Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy (Prof M Cavo MD); Rocky Mountain Cancer Centers— Denver—Midtown, Denver, CO, USA (R Rifkin MD); Matsuyama Red Cross Hospital, Matsuyama, Japan (T Fujisaki MD); GSK, Collegeville, PA, USA (J Ficek PhD, A Mantero PhD, N Pirooz MHA, S Varghese MBBS, R Rogers MS, S Roy-Ghanta MD, P Mukhopadhyay PhD, J Opalinska MD); GSK, London, UK (J Lee PhD, L Eccersley PhD); GSK, Stevenage, UK (A McKeown PhD); GSK, Mississauga, ON, Canada (H Baig BS); GSK, Chicago, IL, USA (J Nielsen PhD); Instituto de Investigación Biomédica de Salamanca, Hospital Universitario de Salamanca– IBSAL–CIC–Ciberonc, Salamanca, Spain (M-V Mateos MD)